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1- Influence of culture time 
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Articular cartilage is a tissue characterized by its poor intrinsic capacity for self-repair. This tissue is 
frequently altered upon trauma or in osteoarthritis (OA), a degenerative disease that is currently incurable. 
Consequently, cartilage markers, such as type II collagen, are degraded whereas atypic molecules, such as 
type I collagen, are newly synthetized. Another essential phenomenon occurring in OA is the upregulation of 
HtrA1, a serine protease targeting upstream receptors of signalling pathways involved in the synthesis of 
articular cartilage markers. OA incurs considerable economic loss for the equine sector. In the view to 
develop new therapies for humans and horses, significant progress in tissue engineering has led to the 
emergence of new generations of cartilage therapy. Matrix-associated autologous chondrocyte implantation 
is an advanced 3D cell-based therapy that holds promise for cartilage repair. The aim of this study is to 
improve the autologous chondrocyte implantation strategy by enhancing the chondrogenic differentiation of 
mesenchymal stem cells (MSCs) in order to increase the type II collagen/ type I collagen ratio. 
Introduction 
Conclusion 
These data indicate that the original BMP-2 + TGF-β1 association seems to be a better solution for the chondrocyte differentiation of equine BM-MSCs, despite the higher expression of type II 
collagen when TGF-β3 is used. The cartilage extracellular matrix (ECM) components also showed enhanced expression for longer culture times, up to 6 weeks. However, the increase in ECM 
production was moderate after 14 days of culture, and the best compromise between high ECM synthesis and minimal production of type I collagen still needs to be clarified. Thus, culture times 
between 14 and 28 days remain the best way to obtain chondrocytes like cells. Before considering in vivo trials in an equine clinical setting, the knockdown strategy should be improved. However, to 
date, our differentiation protocol may be applicable for pre-clinical trials in the horse to help to decide on the best in vitro culture conditions to produce a hyaline-type articular cartilage in vivo. 
Results 
Autologous Chondrocytes Implantation 
First generation Second generation Third generation 
Modified from Dewan AK. Gibson MA., Elisseeff JH., Trice ME. (2014) Evolution of Autologous Chondrocyte 
Repair and Comparison to Other Cartilage Repair Techniques. Biomed Res Int. 2014 : 272481 
2- Effect of RNA interference 
3-BMP-2+TGF-β1  
or BMP-2+TGF-β3 for a better chondrogenic effect? 
Increase in the culture time of MSCs in the presence of BMP-2 and TGF-β1 
until 42 days and its influence on the expression of hyaline articular 
cartilage non specific and specific markers at the mRNA level (A) and 
protein level (B). 
 
Equine MSCs derived from bone marrow were amplified and seeded in collagen sponges 
at P4 (n=3). They were then cultured in hypoxia (3% O2) for 14, 28 and 42 days in the 
presence of incomplete chondrogenic medium (ICM) alone or supplemented with BMP-2 
(50 ng/ml) and TGF-β1 (10 ng/ml) (BMP-2 + TGF-β1). D0: stem cells cultured in 
amplification medium at P4; EAC: equine articular chondrocytes.  
Expression of mRNAs (A) and proteins (B) of articular cartilage specific 
markers during chondrogenic differentiation of MSCs cultured in the 
presence of BMP-2 + TGF-β1 or TGF-β3 alone or in combination with BMP-2. 
 
Equine MSCs derived from bone marrow were amplified and seeded in collagen sponges at 
P4 (n = 2). They were then grown in hypoxia (3% O2) for 7, 14, 21 and 28 days (D7, D14, 
D21 and D28, respectively) in the presence of incomplete chondrogenic medium (ICM) 
alone or enriched with BMP-2 (50 ng/ml) and TGF-β1 (10 ng/ml) (BMP-2 + TGF-β1), TGF-β3 
(10 ng/ml) or BMP-2 (50 ng/ml) and TGF-β3 (10 ng/ml) (BMP-2 + TGF-β3).  
D0: stem cells cultured in amplification medium at P4; EAC: equine articular chondrocytes.  
 Culture time extension leads to an increase of the expression of 
chondrocyte markers, but also of type I collagen.  
 
 The association of BMP-2 and TGF-β1 decreases HtrA1 protein 
expression. 
 
 The Col2a1/ Col1a1 ratio at the mRNA level is not modulated from D28 to 
D42. 
A B 
Effect of Col1a1 and/or Col1a2 siRNAs on the mRNA (A) and protein (B) 
levels of specific and nonspecific markers of chondrocytes derived from 
MSCs cultured 42 days.  
 
Equine MSCs derived from BM were amplified and seeded in type I/III collagen sponges at 
P4 (n=3).They were then cultured in hypoxia (3% O2) for 42 days in incomplete 
chondrogenic medium (ICM) in the presence of BMP-2 (50 ng/ml) and TGF-β1 (10 ng/ml). 
The MSCs were transfected with a control siRNA or Col1a1 and/or Col1a2 siRNAs (50 nM of 
each siRNA was transfected).  
D0: stem cells cultured in amplification medium at P4; EAC: equine articular chondrocytes.  
 RNA interference targeting Col1a2 leads to a more significant knockdown, 
at the mRNA level, compared to a conventional strategy targeting Col1a1. 
The combination of the two siRNA leads to the better Col2a1/Col1 ratio. 
 
 Type I collagen protein expression is not significantly modulated whatever 
the siRNA used. 
 TGF-β3 alone showed promising results at both mRNA and protein levels, 
but, regarding the articular cartilage atypic type I collagen, the previously 
tested association of BMP-2 and TGF-β1 better limits the expression of 
type I collagen at the protein level. Morevoer, the use of TGF-β3 alone 
induces a higher expression of the HtrA1 serine protease compared to 
the previously tested growth factors association.  
This study aims to improve the autologous chondrocyte implantation technique by using equine MSCs from bone marrow differentiated into chondrocytes that can be implanted in the chondral lesion. 
Our previous chondrogenic differentiation protocol lasted 14 days and consisted in an hypoxic 3D culture of MSCs in the presence of chondrogenic factors (BMP-2, TGF-ß1) and siRNAs targeting 
only the alpha 1 chain of type I collagen and Htra1.  
Methods 
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MSCs are seeded 
in type I/II collagen 
sponges 
Hypoxic culture condition 
Optimized 
chondrocyte 
differentiation? 
Culture time  
extended from 28 to 42 days 
RNA interference 
siRNA targeting Col1a1 and 
Col1a2 
 
Chondrogenic factors 
TGF-β3 
TGF-β3 + BMP-2 
TGF-β1 + BMP-2 
 
Here, we explored three parameters that could influence MSC differentiation: culture time, 
chondrogenic factors and siRNA targeting the alpha 2 chain of the type I collagen since type I 
collagen is an heterodimer composed of two alpha 1 and one alpha 2 chain.  
